The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback